Steve Skyrme
Global Head of Customer Experience, Oncology
Pfizer
Check out the incredible speaker line-up to see who will be joining Steve.
Download The Latest AgendaDay Two, 24th September 2020
Thursday, September 24th, 2020
9:20 AM Panel Discussion & Interactive Polling: What are the people, processes and tools you need to increase your data capture and analytics capabilities to gain a deeper understanding of your customers and create personalised services to better support them?
As data capture and analysis becomes more sophisticated, there are many question marks around the full potential of data for the pharma industry. Our expert panel will examine how data can help you to provide more relevant and personalised communications, products and services for your customers.
· How can you better align your internal teams to ensure you successfully capture real-world data from early trial stages through to final product delivery?
· How can you encourage your sales and marketing teams to be more data-driven to increase data capture and analysis to benefit from greater data insights?
· How to capture structured and unstructured data to gain valuable commercial insights and generate informative reports to support your commercial teams
· Cloud vs on-premise: What is the best approach to effectively store internal and external data to service the wider business with actionable intelligence?
· How can you employ data visualisation and other techniques to make data insights user friendly and empower your colleagues and customers better understand product data?
11:00 AM Oxford Style Debate: Commercial teams are prepared to reap the full benefits of advanced digital technologies in 2020 – For & Against
For:
· Advances in AI and machine learning, and an abundance of solutions, are making it easier than ever before for commercial, sales and marketing teams to make digital a core competency
· As the C-suite increasingly values the importance of digital, pharma companies will invest in using digital solutions to guide their sales and marketing strategies
Against:
· Pharma companies still lack the innovation, company mindset and cohesive strategy to move from ‘experimenting with digital’ to ‘scaling it across their global commercial teams’
· Legacy systems and data silos will continue to hamper the implementation of digital and data platforms for many years to come